Search

Search Results

• PO113 | A STRANGE CASE OF RECURRENT ISOLATED DIGITAL ARTERIAL THROMBOSIS M.M. Poggi, D. Bruni | SOC Medicina 1, Nuovo Ospedale Prato, Prato, Italy

  Matteo Maria Poggi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.929

  30

  PDF: 14

• PO108 | DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH VENOUS THROMBOEMBOLISM RECEIVING LONG-TERM IMMUNOSUPPRESSIVE THERAPY AFTER LIVER AND KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE U. Mazzarelli¹, L. Agrelli¹, A. Cirillo¹, C. Crescenzo², M. Triggiani¹, A. Guida³ | ¹Dipartimento di Medicina Interna, Università degli studi di Salerno, Italy; ²UOC Nefrologia e Trapianti di rene; ³Centro per le malattie emorragiche congenite e malattie trombotiche, AOU San Giovanni di Dio e Ruggi d'Aragona Salerno, Italy

  Anna Guida

  26-10-2026

  https://doi.org/10.4081/btvb.2026.924

  34

  PDF: 11

• PO73 | False-positive CT diagnosis of DVT in a patient with severe venous sequelae: a case of bilateral cellulitis L. Jr Valletta, C. De Luca, M. Aversano, C. Caputo, G. Chiarelli, R. Russo, E. Cimino, P. Conca, A. Tufano, G. Iannuzzo, V. Mallardo, M.N.D. Di Minno | AOU Federico II, Napoli, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.342

  676

  PDF: 21

• CO097 | IMPACT OF THE 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CRITERIA IN 1200 WOMEN WITH PRIOR OBSTETRIC ANTIPHOSPHOLIPID SYNDROME J. Alijotas-Reig^1|2|3, E. Esteve-Valverde⁴, L. Saez-Comet⁵, A. Anunciacion-Llunell³, R. Ferrer-Oliveras⁶, E. Lefkou⁷, A. Mekinian⁸, C. Belizna⁹, A. Hoxha¹⁰, A. Tincani¹¹, L. Marozio¹², G. Espinosa¹³, S. de Carolis¹⁴, S. Udry¹⁵, J.O. Latino¹⁵, E. Llurba¹⁶, C.B. Chighizola^17|18, M. Gerosa¹⁹, V. Pengo²⁰, K. Lundelin²¹, P. Rovere-Querini²², V. Canti²², K. Mayer-Pickel²³, T. Reshetnyak²⁴, S. Tabacco²⁵, L. Stojanovich²⁶, B.A. Gonçalves²⁷, S. Morales-Perez¹, F. Miro-Mur³ | ¹Department of Medicine, Universitat Autonoma de Barcelona, Spain; ²Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Spain; ³Systemic Autoimmune Diseases Research Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain; ⁶Obstetrics Department, High-Risk Unit, Hospital Universitario Quironsalud, Barcelona, Spain; ⁷Haematology Unit, Hippokration Hospital of Thessaloniki, Greece; ⁸AP-HP, Hopital Saint-Antoine, Service de Medecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universites, Paris, France; ⁹Vascular and Coagulation Department, University Hospital Angers, Angers, France; ¹⁰Internal Medicine Unit, Thrombotic and Bleeding Disorder Center, University of Padua, Padova, Italy; ¹¹Department of Clinical and Experimental Sciences, University of Brescia, Spedali Civili, Brescia, Italy; ¹²Department of Obstetrics and Gynaecology, Universita di Torino, Torino, Italy; ¹³Systemic Autoimmune Diseases Service, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; ¹⁴Department of Gynaecology, Gemelli Hospital, Catholic University, Roma, Italy; ¹⁵Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina; ¹⁶Obstetrics and Gynaecology Department, High-Risk Unit, University Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ¹⁷Department of Clinical Science and Community Health, University of Milano, Milano, Italy; ¹⁸Unit of Pediatric Rheumatology, ASST G. Pini-CTO, Milano, Italy; ¹⁹Division of Rheumatology, Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy; ²⁰Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy; ²¹Department of Pediatrics, Faculty of Medicine, University of Turku, Turku, Finland; ²²Internal Medicine and Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; ²³Department of Obstetrics, Medical University of Graz, Graz, Austria; ²⁴Department of Systemic Rheumatic Disease, V. A. Nasonova Research Institute of Rheumatology, Moscow, Russia; ²⁵Department of Gynecology, Obstetrics and Urology, Sapienza University of Roma, Roma, Italy; ²⁶University Medical Center, University of Belgrade, Belgrade, Serbia; ²⁷Department of Internal Medicine, Hospital Sant Joan Despí Moises-Broggi, Barcelona, Spain

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.799

  42

  PDF: 11

• CO013 | INDICATIONS AND OUTCOMES OF OPTIONAL INFERIOR CAVA FILTERS IN CANCER-ASSOCIATED THROMBOSIS AND IN NON CANCER PATENTS WITH VENOUS THROMBOEMBOLISM B. Cosmi^1|2, A. Cannizzaro², M. Soldati², L. Borgese², S. Cavara^1|2, M. Sartori², L. Braccischi³, M. Taninokuchi Tomassoni⁴, D. Imberti⁵, V.O. Herasimchyj⁵, C. Mosconi^3|4 | ¹Angiology and Blood Coagulation Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; ²IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; ³Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; ⁴Department of Radiology, IRCCS Azienda Ospedaliero Universitaria Di Bologna, Bologna, Italy; ⁵Department of Medicine and Surgery, University of Parma, Italy; ⁶Haemostasis and Thrombosis Center, Internal Medicine Department, Ospedale di Piacenza, Italy

  Benilde Cosmi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.715

  121

  PDF: 11
• 

  Thromboprophylaxis in primary brain cancer

  Eva N. Hamulyák, Barbara A. Hutten, Nick van Es

  16-04-2026

  https://doi.org/10.4081/btvb.2026.455

  350

  PDF: 155

• CO044 | QUALITY AND SAFETY OF VITAMIN K ANTAGONIST TREATMENT IN PEDIATRIC PATIENTS: A RETROSPECTIVE CLINICAL AUDIT FROM A SINGLE CENTER C. Ambaglio¹, T. Zollner¹, G. Cuni¹, S. Bolognini¹, C. Ticozzi¹, F. Schieppati¹, E. Galimberti¹, O.C. Cretu¹, V. Brusegan¹, F. Zunino¹, F. Duca², M. Marchetti¹, A. Falanga^1|2, L. Barcella¹ | ¹Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ERN-EuroBloodNet - European Reference Network in Rare Hematological Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  Chiara Ambaglio

  26-10-2026

  https://doi.org/10.4081/btvb.2026.746

  42

  PDF: 9

• PO095 | HEPARIN-INDUCED THROMBOCYTOPENIA PRESENTING AS A CIRCUIT-TRIGGERED PULMONARY SYNDROME IN HEMODIALYSIS: A CASE REPORT S.P. Colapietra, M. Gino | Osp. Molinette, Torino, Italy

  Selene Pia Colapietra

  26-10-2026

  https://doi.org/10.4081/btvb.2026.911

  30

  PDF: 10

• PO160 | THE USE OF ANTIDEPRESSANT DRUGS AND BENZODIAZEPINE HYPNOTICS AS AN UNUSUAL RISK FACTOR FOR VTE G. Chiarelli, C. Caputo, M. Romeo, F. Strano, P. Conca, P. Rufolo, M.G. Mazzone, R. Russo, L. Valletta Jr., G. D’Errico, C. De Luca, E. Cimino, A. Tufano | DMCC. "Federico II" University of Naples, Italy

  Antonella Tufano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.976

  36

  PDF: 12

• PO94 | The use of antidepressant drugs and benzodiazepine hypnotics as an unusual risk factor for VTE G. Chiarelli, F. Strano, P. Conca, P. Rufolo, M. G. Mazzone, R. Russo, L. Jr Valletta, G. D’Errico, C. De Luca, E. Cimino, A. Tufano, M.N.D. Di Minno | Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.364

  747

  PDF: 22

• PO158 | A RARE CASE OF ISCHEMIC STROKE: CAROTID WEBS C. Mazzei, I. Costanzo, D. Fumarulo, S. Bernardi, G. Trinchera, M. Littera, M. Mazzetti, C. Tamburini | Medicina Interna Interdisciplinare, A.O.U. Careggi, Firenze, Italy

  Chiara Mazzei

  26-10-2026

  https://doi.org/10.4081/btvb.2026.974

  27

  PDF: 10

• PO82 | Retrospective application of the TH2 score in a multicenter cohort of ITP patients: a reliable predictive tool or a score in need of refinement? C. Giubbilei¹, M. Defina², S. Rosati³, M. Rocco³, A. Votto⁴, F. Simonetti⁵, F. Paoletti⁶, V. Carrai¹ | ¹Hematology Unit, AOU Careggi; ²Hematology unit AOU Senese; ³Hematology Unit Azienda Sanitaria Toscana Centro; ⁴Hematology Unit, AOU Pisana; ⁵Hematology Unit, Ospedale Versilia; ⁶Hematology Unit, Azienda Sanitaria Nord Ovest, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.351

  571

  PDF: 16

• PO102 | EFFICACY AND SAFETY OF VISCOELASTIC TESTING–GUIDED TRANSFUSION IN CIRRHOSIS UNDERGOING INVASIVE PROCEDURES: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS A. Boccatonda¹, E. Campello², A. Napolitano², C. Simion², C. Serra¹, P. Simioni² | ¹Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Via Massarenti N 9, 40138, Bologna, Italy; ²First Chiar of Internal Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, University Hospital of Padova, 35128, Padova, Italy

  Andrea Boccatonda

  26-10-2026

  https://doi.org/10.4081/btvb.2026.918

  21

  PDF: 10
• 

  Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

  Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

  23-05-2022

  https://doi.org/10.4081/btvb.2022.12

  5661

  PDF: 547

• CO016 | PLATELET HYPER-REACTIVITY AND PROCOAGULANT PHENOTYPE IN ESSENTIAL THROMBOCYTHEMIA: INSIGHTS FROM ADVANCED PLATELET FUNCTION TESTING A. Pozzi, G. Rosati, C. Barale, M. Padrini, R.M. Medici, G. Ferrari, E. Mordohovich, M. Tamietti, M. Armenio, M. Geminiani, M. De Gobbi, I. Russo, A. Morotti | Dip. Scienze Cliniche e Biologiche, Torino, Italy

  Alessandro Pozzi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.718

  35

  PDF: 11

• CO15 | Longitudinal coagulation profiling of individuals undergoing gender-affirming hormone therapy: the hyper-gender study A. Napolitano, E. Campello, A. Scala, C. Simion, C. Bulato, S. Gavasso, C. Samà, A. Benetti, S. Toffanin, G. Faggian, R. Scafa, A. Garolla, P. Simioni | First Chair of Internal Medicine, Department of Medicine, University Hospital of Padua; Unit of Andrology and Reproductive Medicine, Department of Medicine, University Hospital of Padua, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.219

  676

  PDF: 18

• PO80 | Heparin-induced thrombocytopenia: a monocentric experience with danaparoid L. D’Innocenzo, S. Sorrentino, M. De Siati, A. Ferretti, E. De Candia | Unit of Haemostasis and Thrombosis Diseases, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.349

  703

  PDF: 14

• PO91 | Disseminated intravascular coagulation with deep vein thrombosis in a frail patient: an extreme manifestation triggered by sepsis during SGLT2i therapy M. Vacca¹, M.V. Cherchi¹, S. Che¹, G.A.M.L. Costanzo², D. Firinu², M. Mantega¹, S. Del Giacco² | ¹Ospedale Sirai, ASL Sulcis, ²Università degli Studi di Cagliari, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.361

  805

  PDF: 20

• CO-22 | CLINICAL FEATURES IN PATIENTS WITH NON-SEVERE HEMOPHILIA A: THE DISCOVERY SCORE PROPOSAL FOR PROPHYLAXIS PRESCRIPTION M.N.D. Di Minno¹, E. Baldacci², C. Biasoli³, A. Borchiellini⁴, F. Daniele⁵, P. Di Gregorio⁶, C. Gorio⁷, G. Malcangi⁸, E. Marchesini⁹, I. Ricca¹⁰, R. Santoro¹¹, S. Siragusa¹², M.R. Villa¹³, E. Zanon¹⁴, A. Tagliaferri¹⁵, A. Coppola¹⁵ | ¹Hub Centre for Thrombotic and Hemorrhagic Disorders, Federico II University Hospital, Napoli, Italy; ²Haematology, University Hospital Policlinico Umberto I, Roma, Italy; ³Interdepartmental Simple Structure for the Management of Hemorrhagic and Thromboembolic Diseases, M. Bufalini Hospital, Cesena, Italy; ⁴Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Torino, Italy; ⁵Haemostasis and Thrombosis Service, Ospedale Civile dell'Annunziata, Cosenza, Italy; ⁶Transfusion Medicine Department, "SS. Annunziata" Hospital, Chieti, Italy; ⁷Pediatric Onco-Hematology Unit, Children's Hospital, ASST-Spedali Civili, Brescia, Italy; ⁸Haemophilia and Thrombosis Center, University Hospital Policlinico-Giovanni XXIII, Bari, Italy; ⁹Hemophilia Centre, SC Vascular and Emergency Department, University of Perugia, Italy; ¹⁰Centro Emofilia, Città della Salute e della Scienza, Torino, Italy; ¹¹Hemostasis and Thrombosis Unit, Azienda Ospedaliero Universitaria Dulbecco, Catanzaro, Italy; ¹²Centro di Riferimento Regionale per le Emocoagulopatie Congenite, Palermo, Italy; ¹³Hematology Unit, Ospedale Santa Maria di Loreto, Napoli, Italy; ¹⁴Hemophilia and Thrombosis Center, University Hospital of Padua, Italy; ¹⁵Hemophilia and Thrombosis Center, Azienda Ospedaliera di Parma, Italy

  Matteo Di Minno

  14-10-2026

  https://doi.org/10.4081/btvb.2026.632

  64

  PDF: 16

• PO041 | VARIABLE CLINICAL RESPONSE TO RECOMBINANT PORCINE FVIII IN ACQUIRED HAEMOPHILIA A: A TWO CASE EXPERIENCE WITH LABORATORY SUPPORTED MONITORING AM. Pizzini¹, M. Bovara², M. Sebastiani², A. Fusco¹, C. Fantoni¹, M. Silingardi¹, R. Mancini², A. Coppola³ | ¹Ambulatorio Emostasi & Trombosi, Dipartimento Medico - Ospedale Maggiore Bologna, Italy; ²Laboratorio Unico Metropolitano - Ospedale Maggiore Bologna, Italy; ³SDD Centro Hub Emofilia e MEC, Azienda Ospedaliero-Universitaria di Parma, Italy

  Attilia Maria Pizzini

  26-10-2026

  https://doi.org/10.4081/btvb.2026.857

  25

  PDF: 9

• PO47 | Hemophilia A and antithrombin deficiency: a case of natural hemostatic rebalancing L. Torrieri, S. Ligia, E. Baldacci, R. Mormile, S. Sorella, R. Ciciani, M. Biglietto, N. Zhdanovskaya, A. Delli Paoli, A. Tirnetta, M. Lorenzon, C. Santoro | Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.316

  634

  PDF: 14

• PO83 | A case of deep vein thrombosis in a patient with systemic mastocytosis M. Leotta, A. Ierardi, A. Strangio, R C. Santoro | UO Emofilia, Emostasi e Trombosi, AOU R Dulbecco, Catanzaro

  22-10-2025

  https://doi.org/10.4081/btvb.2025.352

  758

  PDF: 24
• 

  It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

  Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

  03-08-2023

  https://doi.org/10.4081/btvb.2023.91

  1839

  PDF: 583

• CO-78 | REAL-WORLD MANAGEMENT OF ACQUIRED HEMOPHILIA A: FOCUS ON RECOMBINANT PORCINE FVIII AS FIRST-LINE HEMOSTATIC TREATMENT AND LONG-TERM OUTCOMES M. Leotta, A. Strangio, A. Ierardi, R.C. Santoro | Hemophilia, Hemostasis and Thrombosis Centre, Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Marzia Leotta

  14-10-2026

  https://doi.org/10.4081/btvb.2026.688

  48

  PDF: 17

• PO005 | EXTENDED ANTICOAGULATION WITH DOACS IN PATIENTS AFFECTED BY HEMATOLOGIC MALIGNANCIES AND VENOUS THROMBOEMBOLISM: DOES LOW DOSE FIT ALL? M. Biglietto, S. Sorella, L.V. Cappelli, B. Mandelli, D. Kasmi, E. Baldacci, A. Chistolini | Sapienza University of Roma, Italy

  Mario Biglietto

  26-10-2026

  https://doi.org/10.4081/btvb.2026.821

  19

  PDF: 12
• 

  Expanding the genetic landscape of hereditary thrombophilia: classical defects, novel variants, and genomic perspectives. A narrative review

  Chiara Simion, Elena Campello, Walter Ageno, Paolo Simioni

  28-08-2026

  https://doi.org/10.4081/btvb.2026.427

  1231

  PDF: 157

  SUPPLEMENTARY FILES: 110

• CO-52 | CARDIOVASCULAR EVENTS AND SUBCLINICAL ATHEROSCLEROSIS IN HEMOPHILIA A AND B PATIENTS: A MULTICENTER COHORT STUDY A. Napolitano, E. Zanon, L. Spiezia, G. Camporese, P. Scarinzi, F. Ahmad, G. Saggiorato, C. Bulato, S. Toffanin, S. Gavasso, F. Sartorello, C. Simion, E. Campello, P. Simioni | Hemophilia Center, University Hospital of Padua, Italy

  Angela Napolitano

  14-10-2026

  https://doi.org/10.4081/btvb.2026.662

  53

  PDF: 18

• PO130 | HEMORRHAGIC AND THROMBOTIC COMPLICATIONS DURING DOACS TREATMENT: THE IMPORTANCE OF A REGULAR AND PROLONGED FOLLOW-UP D. Barcellona^1|2, A. Mameli², S. Cornacchini², P. Schirru², L. Fenu², V. Casu², F. Marongiu^1|2 | ¹University of Cagliari, Italy; ²Haemostasis and Thrombosis Unit, Azienda Ospedaliero-Universitaria di Cagliari, Italy

  Doris Barcellona

  26-10-2026

  https://doi.org/10.4081/btvb.2026.946

  35

  PDF: 8
• 

  Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

  Bianca Clerici, Mariangela Scavone, Gian Marco Podda

  20-06-2024

  https://doi.org/10.4081/btvb.2024.127

  2862

  PDF: 891

• PO011 | A TWO CENTERS REAL-WORLD EXPERIENCE WITH ANTI-XA DIRECT ORAL ANTICOAGULANTS IN CANCER PATIENTS WITH UNUSUAL SITE VEIN THROMBOSIS U. Mazzarelli¹, L. Agrelli¹, A. Cirillo¹, C. Caputo², M. Romano², R. Russo², R. Guarrasi³, M. Triggiani¹, A. Tufano², A. Guida⁴ | ¹Dipartimento di Medicina Interna, Università degli studi di Salerno, Italy; ²Dipartimento di Medicina Interna, Università degli studi di Napoli Federico II, Italy; ³UOC Clinica Oncologica; ⁴Centro per le malattie emorragiche congenite e malattie trombotiche AOU San Giovanni di Dio e Ruggi d'Aragona Salerno, Italy

  Anna Guida

  26-10-2026

  https://doi.org/10.4081/btvb.2026.827

  35

  PDF: 11

• PO61 | ACTN1-related thrombocytopenia and severe hyperhomocysteinemia: a case report A. Pozzi, G. Rosati, M. Padrini, S. Laurenti, G. Ferrari, R.M. Medici, C. Barale, I. Russo, A. Morotti | University of Turin, San Luigi Hospital, Orbassano (TO), Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.330

  574

  PDF: 16
• 

  PO38 | PERICATHETER AND SYSTEMIC THROMBOSIS DURING CAR-T LYMPHOCYTAPHERESIS: INCIDENCE AND CLINICAL CORRELATES I. Pansini^1|2, E. Galli¹, A. Corrente², N. Piccirillo^1|2, M. Viscovo^1|2, S. Hohaus^1|2, P. Chiusolo^1|2, F. Sorà^1|2, S. Sica^1|2 | ¹Department of Laboratory and Hematologic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; ²Hematology Section, Department of Radiologic and Hematologic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.532

  442

  PDF: 101

• PO81 | Direct oral anticoagulants in atypical site vein thrombosis: a single centre experience focused on cancer patients U. Mazzarelli¹, A. Guida¹, L. Agrelli¹, M. Amato¹, R. Guarrasi², L. Santaniello², C. Cardamone¹, P. Vitale¹, M. Triggiani¹ | ¹Centro per le Malattie Emorragiche Congenite e Malattie Trombotiche UOC Clinica Immunologica e Reumatologica AOU S. Giovanni di Dio e Ruggi d’Aragona, Salerno; ²UOC Clinica Oncologica AOU S. Giovanni di Dio e Ruggi d’Aragona, Salerno, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.350

  638

  PDF: 24
• 

  PO60 | VEXAS SYNDROME AS A NEW SEVERE THROMBOPHILIC CLONAL CONDITION: A SINGLE CENTRE EXPERIENCE C. Ambaglio¹, E. Galimberti¹, F. Schieppati¹, M. Frigeni², M. Marchetti¹, L. Barcella¹, A. Falanga ^1|3 | ¹Immunohematology and Transfusion Medicine Unit, ASST Papa Giovanni XXIII, Bergamo; ²Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo; ³School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.551

  507

  PDF: 111

• PO53 | Effectiveness and safety of DOACS in patients with renal transplantation A. Ierardi, A. Strangio, M. Leotta, R C. Santoro | UO Emofilia, Emostasi e Trombosi, AOU Renato Dulbecco, Catanzaro, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.322

  648

  PDF: 18
• 

  PO18 | THE THROMBO-INFLAMMATION AXIS AS PREDICTOR OF TOXICITY IN PATIENTS TREATED WITH CAR-T CELLS C. Fernández-Arias¹, M. Marcos-Jubilar¹, M. Panizo¹, C. Vázquez-Puerta², J.R. González-Porras², M. Ibáñez¹, A. Queralt¹, M. Carrasco¹, M.B. Villacrés¹, C. Conde¹, P. Elizalde¹, S. Huerga¹, A. Alfonso¹, P. Rodríguez-Otero¹, S. Villar¹, M.A. Canales¹, J. Rifón¹, F. Prósper¹, J.A. Páramo¹, J. Orbe¹, R. Lecumberri¹ | ¹Clínica Universidad de Navarra, Pamplona; ²Hospital Clínico Universitario de Salamanca, Salamanca, Spain

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.513

  528

  PDF: 90

• CO077 | PLATELET MIR-144-5P REGULATES COX-1/2 EXPRESSION AND MODULATES ASPIRIN RESPONSE IN PATIENTS WITH CARDIOMETABOLIC RISK P. Simeone¹, R. Liani¹, V. Abbonante², M. Alfonsetti¹, M. Frezza¹, P. Lanuti¹, A. Recchiuti³, A. Balduini², F. Santilli¹ | ¹Department of Medicine and Aging, and Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy; ²Department of Molecular Medicine, University of Pavia, Pavia, Italy; ³Department of Medical, Oral, and Biotechnological Science, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy

  Paola Giustina Maria Simeone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.779

  32

  PDF: 9
• 

  OC02 | INCIDENCE AND PREDICTORS OF ARTERIAL THROMBOSIS IN CANCER PATIENTS: RESULTS FROM THE PROSPECTIVE COMPASS-ARTERIAL CANCER ASSOCIATED THROMBOSIS (COMPASS-ARTECAT) STUDY M. Drakopoulou¹, I. Diamandoulaki², P. Baglaridis¹, P. Las Casa³, P. Van Dreden⁴, K. Toutouzas¹, G. Gerotziafas^4|5 | ¹First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece; ²Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; ³Sorbonne University, INSERM UMR_S_938, CRSA, Research Department "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Haemostasis," Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France; ⁴Diagnostica Stago, clinical research, Gennevilliers, France; ⁵Center of Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Ill., USA

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.486

  518

  PDF: 131
• 

  Cancer-associated thrombosis: limitations of conventional models and advances with endothelial cell-based microfluidics incorporating thrombin generation

  Dongyue Fan, Araci M.R. Rondon, Henri H. Versteeg

  16-04-2026

  https://doi.org/10.4081/btvb.2026.438

  824

  PDF: 147

• PO149 | MANAGEMENT OF ANTITHROMBOTIC THERAPY IN A PATIENT WITH HEMOPHILIA C AND ATRIAL FIBRILLATION E. Marrone¹, G. Ruggiero², E. Cimino³, P. Conca³, C. Miele⁴, F. Gallucci¹, A. Abate¹, C. Romano¹, D. Leosco², U. Valentino¹ | ¹Department of Medicine 3, Cardarelli Hospital, Napoli, Italy; ²School of Specialization in Geriatrics; ³Department of Internal Medicine and Blood Coagulation; ⁴Department of Laboratory Medicine and Transfusion, Federico II University, Napoli, Italy

  Emiliana Marrone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.965

  25

  PDF: 11

• PO092 | HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH GUILLAIN-BARRÉ SYNDROME: A POSSIBLE LINK WITH IMMUNE DYSREGULATION S. Bernardi¹, F. Cei², R. Lavecchia³, L. Chiarugi⁴, R. Tarquini⁵ | ¹Università degli Studi di Firenze, Italy; ²Osp. S. Giuseppe Empoli, Italy

  Sofia Bernardi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.908

  29

  PDF: 12

• CO056 | URINARY MARKERS OF PLATELET ACTIVATION AND OXIDATIVE STRESS IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES M. Alfonsetti¹, P. Simeone¹, R. Liani¹, M. Frezza¹, B. Di Marco¹, A. Cipollone¹, D. D’ Ardes¹, T. Taverriti¹, C. Della Penna¹, L. Cantagallo¹, G. Ciferni¹, L. Del Rosso¹, M. Caporale¹, S. Brandolino², E. Vitacolonna², P. Di Carlo³, F. Cipollone¹, F. Santilli¹ | ¹Department of Medicine and Aging Sciences, Center for Advanced Studies and Technology (CAST), University of Chieti, Chieti, Italy, University General Medicine Division, Medical Department, SS. Annunziata Hospital, Chieti, Italy; ²Department of Medicine and Aging, School of Medicine and Health Sciences, G. d'Annunzio University, Chieti, Italy; ³Department of Innovative Technologies in Medicine & Dentistry, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy

  Paola Giustina Maria Simeone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.758

  40

  PDF: 11
• 

  Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

  Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

  16-05-2024

  https://doi.org/10.4081/btvb.2024.120

  1798

  PDF: 725

• CO20 | Coagulation alterations as prognostic indicators in septic patients L. Baratti¹, S. N. Pasturenzi¹, P. Onorato², W. Ageno³, F. Cortellaro², M.P. Donadini^2,4 | ¹Scuola di Medicina, Università degli Studi dell’Insubria, Varese; ²Pronto Soccorso e Medicina d’Urgenza, Ospedale di Circolo, Varese; ³Dipartimento di Medicina, Università degli Studi di Padova; ⁴Dipartimento di Medicina e Chirurgia, Università degli Studi dell’Insubria, Varese, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.226

  645

  PDF: 17

• PO078 | CARDIOVASCULAR EVENTS AND SUBCLINICAL ATHEROSCLEROSIS IN HEMOPHILIA A AND B PATIENTS: A MULTICENTER COHORT STUDY A. Napolitano, E. Zanon, L. Spiezia, G. Camporese, P. Scarinzi, F. Ahmad, G. Saggiorato, C. Bulato, S. Toffanin, S. Gavasso, P. Zerbinati, C. Simion, E. Campello, P. Simioni | Department of Medicine, University of Padova, Italy

  Angela Napolitano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.894

  24

  PDF: 12

• CO49 | The burden of cerebral small vessel disease in ITTP patients from acute phase to remission A. Truma^1,2, F. M. Lo Russo¹, G. Conte^1,2, I. Mancini¹, M. Abbattista¹, J. A. Giannotta¹, A. Artoni¹, B. Ferrari¹, P. Agosti^1,2, F. M. Triulzi^1,2, F. Peyvandi^1,2 | ¹Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan; ²Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.259

  629

  PDF: 16

• CO024 | THE ROLE OF BLOOD CLOTTING AND ENDOTHELIAL ACTIVATION IN THE STRATIFICATION OF BLEEDING AND THROMBOTIC RISK OF ATRIAL FIBRILLATION ON ORAL ANTICOAGULANT THERAPY: INSIGHTS FROM THE STRAT-AF 2 STUDY F. Alfano^1|2, AM. Gori^1|2, A. Bertelli¹, G. Ciarrocca Taranta¹, M. Di Gioia², F. Cesari¹, A. Rogolino¹, A. Sorrentino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ²Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Francesco Alfano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.726

  41

  PDF: 13

• PO42 | Acquired Von Willebrad syndrome in patients with myeloproliferative syndrome: literature review and single-center experience A. Strangio, M. Leotta, A. Ierardi, R C. Santoro | UO Emofilia, Emostasi e Trombosi, AOU R Dulbecco, Catanzaro, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.305

  559

  PDF: 23

• PO123 | PERIOPERATIVE MANAGEMENT OF FEMORAL FRACTURE SURGERY IN AN ELDERLY PATIENT WITH ACQUIRED HEMOPHILIA A RECEIVING EMICIZUMAB C. Simion, E. Zanon, B. Stocco, G. Saggiorato, F. Sartorello, C. Bulato, P. Simioni | Department of Medicine, University of Padova, Italy

  Chiara Simion

  26-10-2026

  https://doi.org/10.4081/btvb.2026.939

  22

  PDF: 10
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  2151

  PDF: 1376

• CO01 | Statin therapy for the prevention of venous thromboembolism in cancer patients: a systematic review and meta-analysis F. Catalani, R. Del Giorno, R. Canevascini, W. Ageno, L. Gabutti, G. Prouse, L. Giovannacci | Ospedale Regionale di Bellinzona, Switzerland.

  22-10-2025

  https://doi.org/10.4081/btvb.2025.199

  706

  PDF: 14

• CO-73 | WHEN BLEEDING MIMICS THROMBOSIS: DIAGNOSTIC DELAY AND THROMBOTIC COMPLICATIONS IN ACQUIRED HEMOPHILIA A R. Tomasello¹, M. Mattana¹, S. Raso¹, F. Schirò¹, P. Polidori², M.I. Di Lena³, F. La Gattuta⁴, M. Napolitano¹ | ¹Ematologia e malattie rare, PO Cervello di Palermo, Italy; ²Farmacia ospedaliera, PO Cervello di Palermo, Italy; ³Direzione medica, PO Cervello di Palermo, Italy; ⁴Radiologia interventistica, PO Villa Sofia di Palermo, Italy

  Riccardo Tomasello

  14-10-2026

  https://doi.org/10.4081/btvb.2026.683

  64

  PDF: 13
• 

  Anticoagulation in advanced renal failure: do factor XI/XIa inhibitors represent the long-awaited shift?

  Domenico Prisco, Edoardo Biancalana, Danilo Malandrino, Irene Mattioli

  23-10-2026

  https://doi.org/10.4081/btvb.2026.595

  66

  PDF: 35

• PO129 | CLINICAL BENEFIT OF RECOMBINANT ADAMTS13 IN CTTP ASSOCIATED WITH HOMOZYGOUS PD173G MUTATION AND UNDETECTABLE ACTIVITY M. Sacco¹, S. Lancellotti¹, M. Basso¹, R. De Cristofaro^1|2 | ¹Servizio Malattie Emorragiche e Trombotiche, Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italy; ²Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica S. Cuore, Roma, Italy

  Raimondo De Cristofaro

  26-10-2026

  https://doi.org/10.4081/btvb.2026.945

  23

  PDF: 10

• CO41 | Failure in assisted reproductive techniques: insights from the first registry E. Grandone^1,3,4, C. Lodigiani², D. Colaizzo³, M. Passaretti², J. Khizroeva⁴, A. De Laurenzo³, P. Totaro⁵, E. Bucherini⁶, D. Baldini⁷, V. Bitsadze⁴, A. Makatsarya⁴, M. Mastroianno³, G. Piazza⁸, M. Othman⁹, M. Margaglione¹ | ¹University of Foggia, Italy; ²Humanitas University, Rozzano, Italy; ³IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; ⁴First Sechenov University, Russia; ⁵Santa Maria Hospital, Bari, Italy; ⁶Angiologia, Faenza, Italy; ⁷Momo Fertilife, Bisceglie, Italy; ⁸Brigham Women Hospital, USA; ⁹Queen’s University, Kingston, Canada

  22-10-2025

  https://doi.org/10.4081/btvb.2025.310

  580

  PDF: 15

• PO116 | MONOCENTRIC EXPERIENCE OF DOACS REVERSAL MANAGEMENT AT L SACCO HOSPITAL, MILAN: A REAL-WORLD RETROSPECTIVE STUDY A. Veltroni, C. Sitzia, O. Di Bartolo, IM Burgo, MC. Carraro, S. Crivelli, C. Masseroni, GB. Inghilleri | Medicina Trasfusionale, Ospedale L. Sacco, Milano, Italy

  Alessio Veltroni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.932

  21

  PDF: 10

• CO-89 | FEMORAL FRACTURE SURGERY IN AN ELDERLY, FRAIL PATIENT WITH ACQUIRED HEMOPHILIA A RECEIVING EMICIZUMAB PROPHYLAXIS: A CASE REPORT C. Simion^1|2, E. Zanon^1|2, B. Stocco^1|2, F. Sartorello¹, C. Bulato¹, G. Saggiorato¹, P. Simioni^1|2 | ¹First Chair of Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Italy; ²Hemophilia Center, Padova University Hospital, Italy

  Chiara Simion

  14-10-2026

  https://doi.org/10.4081/btvb.2026.699

  49

  PDF: 20

• CO-66 | PREGNANCY OUTCOMES AND PERIPARTUM MANAGEMENT IN WOMEN WITH CONGENITAL FIBRINOGEN DISORDERS: A SINGLE-CENTRE EXPERIENCE T. Martini¹, B. Borsellino^1|2, B. Pollio¹ | ¹Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.676

  57

  PDF: 14
• 

  PO23 | IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA RELATED TO DELAYED IMMUNE CHECKPOINT INHIBITORS TOXICITY: A CASE REPORT E. Galimberti¹, F. Schieppati¹, C. Ambaglio¹, M. Marchetti¹, L. Barcella¹, A. Falanga^1|2 | ¹Immunohematology and Transfusion Medicine Unit, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milan-Bicocca, Milano, Italy

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.518

  419

  PDF: 86

• CO051 | PROTEIN S HEERLEN AND OTHER PROS1 GENE VARIANTS IN PROTEIN S-DEFICIENT PATIENTS: A SINGLE-CENTER STUDY F. Ramundo, T. Malara, M. Rossi, T. Za, AM. Ciminello, S. Betti, F. Bartolomei, F. Di Landro, P. Arcuri, P. Chiusolo, V. De Stefano, E. Rossi | Catholic University, Fondazione Policlinico A.Gemelli IRCCS, Italy

  Francesco Ramundo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.753

  36

  PDF: 10
• 

  Direct oral anticoagulants: does one dose fit all? Why, when and how testing

  Armando Tripodi

  15-01-2026

  https://doi.org/10.4081/btvb.2026.418

  1439

  PDF: 296
• 

  The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

  Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

  04-09-2024

  https://doi.org/10.4081/btvb.2024.144

  2091

  PDF: 359

  SUPPLEMENTARY MATERIAL: 218

• CO-86 | A RARE CASE OF ACQUIRED HEMOPHILIA A ASSOCIATED WITH MYELOPROLIFERATIVE NEOPLASM A. Ierardi, A. Strangio, M. Leotta, R.C. Santoro | Hemophilia, Hemostasis and Thrombosis Unit, Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Antonella Ierardi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.696

  52

  PDF: 20
• 

  Lupus anticoagulant: a never-ending story. New insights from anti-prothrombin antibodies

  Vittorio Pengo

  28-08-2026

  https://doi.org/10.4081/btvb.2026.469

  339

  PDF: 204

• PO66 | Viscoelastic tests in disseminated intravascular coagulation associated with aortic aneurysm A. M. Pizzini¹, C. Biasoli², M. Bovara³, E. Gesuete¹, A. Fusco¹, C. Fantoni¹, P. Pedrazzi², R. Mancini³, M. Silingardi¹ | ¹Ambulatorio Emostasi & Trombosi, Dipartimento Medico, Ospedale Maggiore AUSL Bologna; ²SSI Presa in Carico delle Malattie Emorragiche e Tromboemboliche della Romagna; ³Laboratorio Unico Metropolitano AUSL Bologna, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.335

  656

  PDF: 18

• CO-46 | MILD HEMOPHILIA A AND JOINT HEALTH IN REAL LIFE: IS THAT AN EMERGING ISSUE? A SINGLE CENTER EXPERIENCE G. Murante^1|2|3, F. Valeri^1|2, S. Bergonzi^1|2|3, M. Capetta^1|2|3, C. Dainese^1|2, A. Valpreda⁴, R. Pastorino^1|3, F. Bocchi^1|3, B. Bruno^2|3, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza of Turin, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, University of Turin, Italy; ³Dep. of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ⁴Central Lab. Baldi and Riberi, AOU Città della Salute e della Scienza of Turin, Italy

  Giovanni Murante

  14-10-2026

  https://doi.org/10.4081/btvb.2026.656

  49

  PDF: 15

• CO094 | ASSESSMENT OF THE MINIMAL EFFECTIVE DOSE OF AVATROMBOPAG IN IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTER REAL-WORLD STUDY A. Baffioni¹, C. Giubbilei¹, G. Giustini¹, A.M. Vannucchi², V. Carrai³ | ¹SOD Ematologia, Università degli studi di Firenze, Italy; ²Center for Innovation and Research in Myeloproliferative Neoplasms, SOD Ematologia, Azienda Ospedaliera Universitaria Careggi, Università degli studi di Firenze, Italy; ³SOD Ematologia, Dipartimento di Oncologia, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

  Agnese Baffioni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.796

  38

  PDF: 11

• PO77 | The clinical awareness of mixing test interpretation in the era of complex reporting algorithm: do we forget the origins? A. Fassina, L. De Valentin, S. Luzi, R. Turrini, A. Antico, L. Zardo | Laboratorio Analisi Castelfranco Veneto, ULSS Marca Trevigiana, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.346

  636

  PDF: 17
• 

  Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

  Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

  17-10-2022

  https://doi.org/10.4081/btvb.2022.40

  3066

  PDF: 434

• PO89 | Apixaban for secondary prevention of venous thromboembolism in hemodialysis patients: pharmacokinetic profile and safety outcomes S. Guglielmo¹, E. De Bon², L. Scarano¹, R. Fabris¹, E. Pierobon³, S. Barbar² | ¹Internal Medicine, Department of Medicine; ²Thrombotic and Hemorrhagic Disorders Unit, Department of Medicine; ³Nephrology and Dialysis Unit, Azienda ULSS 6 Euganea, Cittadella and Camposampiero, Padua, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.359

  855

  PDF: 16

• PO053 | PLATELET AGGREGATION AND THROMBIN GENERATION IN MULTIPLE MYELOMA: A PROSPECTIVE STUDY M. Biglietto, M. Mormile, A. Piciocchi, F. Fazio, M. Capriata, S. Sorella, E. Baldacci, A. Chistolini, M.T. Petrucci, C. Santoro | Sapienza University of Roma, Italy

  Mario Biglietto

  26-10-2026

  https://doi.org/10.4081/btvb.2026.869

  22

  PDF: 11

• CO039 | CLINICAL SAFETY AND MONITORING OF APIXABAN IN HEMODIALYSIS PATIENTS: A PROSPECTIVE STUDY S. Guglielmo¹, M. Lovisotto¹, E. De Bon², E. Pierobon³, S. Barbar² | ¹Internal Medicine, Department of Medicine; ²Thrombosis and Haemostasis Unit, Department of Medicine; ³Nephrology and Dialysis Unit, Azienda Ulss 6 Euganea, Cittadella and Camposampiero, Padova, Italy

  Simone Guglielmo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.741

  40

  PDF: 13

• PO76 | Thrombosis associated with midline in autoimmune patient: a case report on the use of apixaban in a real-world setting M.V. Cherchi, M. Anedda, S. Che, M. Vacca, M. Caboni, M. Mantega | Department of Internal Medicine, ASL Sulcis, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.345

  601

  PDF: 29

• CO059 | EXTRACELLULAR VESICLES AS BIOMARKERS IN FAMILIAL HYPERCHOLESTEROLEMIAS TREATED WITH EVINACUMAB C. Samà¹, A. Benetti¹, M.G. Lupo², M. Biolo¹, C. Portinari¹, S. Zambon¹, A. Zambon¹, N. Ferri², C.M. Radu¹, P. Simioni¹ | ¹First Chair of Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy; ²Department of Medicine, Padova University Hospital, Padova, Italy

  Chiara Sama'

  26-10-2026

  https://doi.org/10.4081/btvb.2026.761

  30

  PDF: 11

• PO061 | LONG-TERM HEADACHE IMPROVEMENT WITH VITAMIN K ANTAGONISTS IN PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME: 2-YEAR OBSERVATIONAL COHORT A. Hoxha^1|2, C. Belizna³, E. Esteve-Valverde⁴, A. Prundean⁵, A. Godon⁶, G. Gobbo^1|2, A. Anunciación-Llunell^7|8|9, R. Ferrer-Oliveras¹⁰, J.O. Latino¹¹, S. Udry¹¹, J. Alijotas-Reig^7|8|9 | ¹Department of Medicine, University of Padua, Padova, Italy; ²Internal Medicine Unit, Thrombosis and Bleeding Disorder Center, University Hospital of Padua, Padova, Italy; ³Vascular and Coagulation Department, University Hospital Angers, Angers, France; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵University of Angers, Inserm, CNRS, MITOVASC, SFR ICAT, Angers, France; ⁶Centre Hospitalier Universitaire Angers, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Laboratoire d'Hématologie, Université d'Angers, Nantes Université, Angers, France; ⁷Department of Medicine, Universitat Autònoma de Barcelona, Spain; ⁸Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, Spain; ⁹Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca, Barcelona, Spain; ¹⁰Obstetrics Department, High-Risk Unit, Hospital Universitario Quirónsalud, Barcelona, Spain; ¹¹Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.877

  22

  PDF: 12

• PO125 | ROMIPLOSTIM FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN ADVANCED SOLID TUMORS: A SINGLE-CENTER EXPERIENCE G. Giustini¹, A. Baffioni¹, C. Giubbilei¹, A.M. Vannucchi², V. Carrai³ | ¹SOD Ematologia, Università degli studi di Firenze, Italy; ²Center for Research and Innovation of Myeloproliferative Neoplasms, SOD Ematologia, AOU Careggi, Università degli studi di Firenze, Italy; ³SOD Ematologia, Dipartimento di Oncologia, AOU Careggi, Firenze, Italy

  Ginevra Giustini

  26-10-2026

  https://doi.org/10.4081/btvb.2026.941

  21

  PDF: 10

• CO107 | PREGNANCY IN A YOUNG WOMAN WITH SEVERE THROMBOCYTOPENIA ASSOCIATED WITH GNE GENE MUTATION S. Bonafini¹, A. Meneguzzi¹, A. Savoia², S. Uccella³, V. Tamborrino³, S. Cesaro³, E. Bonetti³, A. Giuffrida⁴, P. Minuz¹, C. Fava¹ | ¹Dip. Medicina, Azienda Ospedaliera Universitaria Integrata Verona, Italy; ²Dip di Ingegneria per la Medicina di innovazione, Università di Verona, Italy; ³Dip. Materno-Infantile, Azienda Ospedaliera Universitaria Integrata Verona, Italy; ⁴Dip. Medicina trasfusionale, Azienda Ospedaliera Universitaria Integrata Verona, Italy

  Sara Bonafini

  26-10-2026

  https://doi.org/10.4081/btvb.2026.809

  33

  PDF: 9

• CO030 | MILD HEMOPHILIA A AND JOINT HEALTH IN REAL LIFE: IS THAT AN EMERGING ISSUE? A SINGLE CENTER EXPERIENCE G. Murante^1|2|3, F. Valeri^1|2, S. Bergonzi^1|2|3, M. Capetta^1|2|3, C. Dainese^1|2, A. Valpreda⁴, R. Pastorino^1|3, F. Bocchi^1|3, B. Bruno^2|3, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza di Torino, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, Università di Torino, Italy; ³Dep. of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ⁴Central Lab. Baldi and Riberi, AOU Città della Salute e della Scienza di Torino, Italy

  Giovanni Murante

  26-10-2026

  https://doi.org/10.4081/btvb.2026.732

  44

  PDF: 11

• PO33 | Whole blood hypercoagulable profiles in patients with rheumatoid arthritis L. Spiezia¹, A. Giollo², C. Samà¹, A. Benetti¹, L. Di Luozzo², M. Salvato², A. Doria², P. Simioni¹ | ¹First Chair of Internal Medicine, Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, University Hospital of Padova; ²Rheumatology Unit, Department of Medicine, University Hospital of Padova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.296

  634

  PDF: 18

• PO70 | Clinical safety and monitoring of apixaban combined with tacrolimus and everolimus in kidney transplant patients: a prospective study S. Guglielmo¹, E. De Bon², L. Scarano¹, R. Fabris¹, E. Pierobon³, S. Barbar² | ¹Internal Medicine, Department of Medicine, Azienda ULSS 6 Euganea, Cittadella; ²Thrombotic and Hemorrhagic Disorders Unit, Department of Medicine, Azienda ULSS 6 Euganea, Cittadella; ³Nephrology and Dialysis Unit, Azienda ULSS 6 Euganea, Cittadella and Camposampiero, Padova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.339

  641

  PDF: 26

• CO055 | COMPARISON OF VISCOELASTIC COAGULATION MONITOR AND ROTATIONAL THROMBOELASTOMETRY FOR HEMOSTATIC PHENOTYPING AND OUTCOME PREDICTION IN SEPSIS G. Gottardi, E. Campello, C. Simion, C. Samà, A. Benetti, C. Bulato, D. Regazzo, G.P. Arcidiacono, P. Simioni | Department of Medicine, University of Padua, Italy

  Giovanni Gottardi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.757

  32

  PDF: 13

• CO-25 | MILD HEMOPHILIA A AND JOINT HEALTH IN REAL LIFE: IS THAT AN EMERGING ISSUE? A SINGLE CENTER EXPERIENCE F. Valeri¹, G. Murante¹, C. Dainese¹, M. Capetta¹, S. Bergonzi¹, R. Pastorino¹, F. Bocchi¹, B. Bruno², A. Borchiellini¹ | ¹Regional Centre for Haemorrhagic and Thrombotic Disease, Hematology Division, AOU Città della Salute e della Scienza, Torino, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, Department of Molecular Biotechnology and Health sciences, University of Turin, Italy

  Federica Valeri

  14-10-2026

  https://doi.org/10.4081/btvb.2026.635

  53

  PDF: 15
• 

  OC13 | VON WILLEBRAND FACTOR PREDICTS POOR OUTCOME IN PANCREATIC CANCER AND MEDIATES TUMOR-ENDOTHELIUM INTERACTIONS FACILITATING METASTASIS B. Ünlü¹, Z. Zhao¹, N. Joshi¹, S. De¹, A. Chion¹, I. Schoen¹, J. O’Donnell¹, M. Flick², M. Fishel^3|4, J. O’Sullivan¹ | ¹School of Pharmacy and Biomolecular Sciences, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland; ²UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, USA; ³IU Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA; ⁴Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.496

  485

  PDF: 96

• PO58 | Gender differences in primary haemostasis A. Becchetti², M. Brambilla², M. Conti², D. Trabattoni², E. Tremoli³, M. Camera^1,2 | ¹Department of Pharmaceutical Sciences, Università degli Studi di Milano; ²Centro Cardiologico Monzino IRCCS, Milan; ³Maria Cecilia Hospital, Cotignola (RA), Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.327

  650

  PDF: 13
• 

  Where cancer meets thrombosis: thrombo-inflammatory landscape of cancer-associated thrombosis

  Victor Zibara, Jeffrey I. Zwicker

  16-04-2026

  https://doi.org/10.4081/btvb.2026.442

  574

  PDF: 172

• PO019 | LONGITUDINAL COAGULATION PROFILING BY THROMBIN GENERATION AND CIRCULATING MICROVESISCLES OF INDIVIDUALS UNDERGOING GENDER-AFFIRMING HORMONE THERAPY E. Campello, A. Scala, A. Napolitano, C. Simion, C. Bulato, S. Toffanin, S. Gavasso, B. Serena, A. Montagna, A. Garolla, P. Simioni | Department of Medicine, University of Padova, Italy

  Elena Campello

  26-10-2026

  https://doi.org/10.4081/btvb.2026.835

  27

  PDF: 11
• 

  OC11 | COMPLEXITIES IN MANAGING ANTITHROMBOTIC THERAPY IN PATIENTS WITH CANCER APPROACHING END-OF-LIFE: A MIXED METHOD INTEGRATION USING JOINT DISPLAY ANALYSIS E. Baddeley¹, L. Van’t Walderveen², H. Enggaard³, M. Søgaard⁴, D. Abbel², S. Cannegieter², M. Edwards¹, C. Font⁵, J. Goedegebuur², F.A. Klok², K.J. Lifford¹, I. Mahé⁶, S.P. Mooijaart², S.I.R. Noble¹, M. Pearson⁷, K. Seddon¹, S. Sivell¹, S. Szmit⁸, S Trompet², A.A. Højen⁴ | ¹Cardiff University, Cardiff, UK; ²Leiden University Medical Center, Leiden, The Netherlands; ³Aalborg University Hospital, Aalborg, Denmark; ⁴Aalborg University and Aalborg University Hospital, Aalborg, Denmark; ⁵Hospital Clinic Barcelona, Barcelona, Spain; ⁶Paris Cité Université, Paris, France; ⁷Hull York Medical School, Hull, UK; ⁸Centre of Postgraduate Medical Education, Warsaw, Poland

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.494

  457

  PDF: 111

• PO099 | CORRELATION BETWEEN DIRECT ORAL ANTICOAGULANTS PLASMA LEVELS AND BRAIN VASCULAR EVENTS L. Riva¹, M. Paolucci², S. Forlivesi², M. Gentile², G. Casella¹, A. Zini², R. Marcucci³ | ¹UOC Cardiologia Ospedale Maggiore AUSL Bologna, Italy; ²IRCCS Istituto delle Scienze Neurologiche di Bologna UOC Neurologia e Rete Stroke metropolitana Ospedale Maggiore AUSL Bologna, Italy; ³SOD Malattie Aterotrombotiche AOU Careggi Università degli Studi di Firenze, Italy

  Letizia Riva

  26-10-2026

  https://doi.org/10.4081/btvb.2026.915

  27

  PDF: 10

• PO044 | UPDATING MANAGEMENT OF ACQUIRED HEMOPHILIA A USING EMICIZUMAB: REAL-WORLD OUTCOMES BY A COLLABORATIVE NETWORK OF 3 ITALIAN CENTERS MI. Tassoni¹, BM. Roccon¹, A. Dalla Salda², R. Benedetti³, R. Rossi⁴, C. Cattabiani⁴, G. Quintavalle¹, A. Casali², D. Imberti³, A. Coppola¹ | ¹SSD Centro Hub Emofilia e Malattie Emorragiche Congenite, Azienda Ospedaliero-Universitaria di Parma, Italy; ²SOC Medicina Interna per acuti ad indirizzo metabolico ed emocoagulativo, Azienda USL IRCCS Reggio Emilia, Italy; ³Centro Emostasi e Trombosi, Medicina Interna, Azienda USL Piacenza, Italy; ⁴Lab. di Coagulazione, UOC Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Italy

  Antonio Coppola

  26-10-2026

  https://doi.org/10.4081/btvb.2026.860

  26

  PDF: 10

• PO004 | SEX-RELATED DIFFERENCES AND PREDICTORS OF MORTALITY IN MAJOR ORTHOPEDIC SURGERY: INSIGHTS FROM THE ORTHO-START REGISTRY A. de Laurenzo¹, E. Antonucci², C. Rostagno³, D. Barcellona⁴, D. Colaizzo¹, G. di Rienzo⁵, F. Gorgoglione¹, G. Maccagnano⁶, F. Marongiu², M. Mastroianno¹, M. Marzolo⁷, L. Mirabella⁶, B. Moretti⁸, A.M. Moretti⁹, A. Ostuni⁶, G. Palareti², M. Margaglione⁶, E. Grandone^1|6 | ¹Fondazione I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni R. (Foggia), Italy; ²Fondazione Arianna, Bologna, Italy; ³Department of Internal and Postoperative Medicine, Careggi University Hospital, Firenze, Italy; ⁴Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; ⁵UOC Patologia Clinica-Ospedale Altamura ASL Bari, Italy; ⁶University of Foggia, Policlinico Riuniti Foggia, Italy; ⁷Angiology Unit, Ospedale di Rovigo, Rovigo, Italy; ⁸School of Medicine, AOU Consorziale Policlinico, University of Bari "Aldo Moro", Italy; ⁹President of GISeG (Italian Group for Health and Gender), Bari, Italy

  Elvira Grandone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.820

  24

  PDF: 11

• PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY? G. Ciarrocca Taranta¹, G. Pansini², S. Orlandini², O. Para³, M. Di Gioia⁴, A. Rogolino⁴, G. Barbieri¹, R. Marcucci^1|4, A. Della Puppa² | ¹Dep of Experimental and Clinical Medicine, University of Florence, Italy; ²Neurosurgical Dep, Careggi University Hospital, Firenze, Italy; ³Internal Medicine 1 Careggi University Hospital, Firenze, Italy; ⁴Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.873

  27

  PDF: 13

• CO-87 | SPONTANEOUS HEMATOMA IN A PATIENT WITH POLYCYTHEMIA VERA: A CASE OF ACQUIRED VON WILLEBRAND DISEASE? A. Strangio, A. Ierardi, M. Leotta, R.C. Santoro | Hemophilia center, AOU Renato Dulbecco, Catanzaro, Italy

  Alessandra Strangio

  14-10-2026

  https://doi.org/10.4081/btvb.2026.697

  63

  PDF: 19

• PO68 | Whole blood hypercoagulable profiles in a patient with markedly elevated lipoprotein(A) plasma levels and thrombotic complications: a case report C. Portinari, M. Biolo, A. Napolitano, L. Spiezia, A. Colpo, S. Zambon, A. Zambon, P. Simioni | Department of Medicine, Padova University Hospital, Padova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.337

  647

  PDF: 26

• CO33 | Acquired hemophilia A in Liguria, Italy: what six years of data reveal C. Vernarecci¹, A. C. Molinari¹, P. Ballarino², M. Caiti², E. Cenni², P. Moscatelli², L. Banov¹ | ¹IRCCS Istituto Giannina Gaslini, Genova; ²IRCCS Policlinico San Martino, Genova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.240

  617

  PDF: 30

• PO087 | BEYOND POSITIVITY: THE HIERARCHICAL ROLE OF IMMUNOASSAYS IN HEPARIN INDUCED THROMBOCYTOPENIA G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^1|2, C. Dainese^1|2, A. Valpreda⁴, R. Pastorino^1|3, F. Bocchi^1|3, A. Porreca⁵, B. Bruno^2|3, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza di Torino, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, Università di Torino, Italy; ³Dep. of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ⁴Central Lab. Baldi and Riberi, AOU Città della Salute e della Scienza di Torino, Italy; ⁵Dep. of Human Sciences and Quality of Life Promotion, Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Italy

  Giovanni Murante

  26-10-2026

  https://doi.org/10.4081/btvb.2026.903

  24

  PDF: 11